Understanding disparities in lupus outcomes among different racial and ethnic groups
DP22-002 Racial/ethnic and socioeconomic disparities in biologic and clinical SLE outcomes
This study is looking for people with lupus to help us understand how different backgrounds, like race and income, affect their health and treatment, so we can improve care for everyone living with this condition.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10846544 on NIH RePORTER |
What this research studies
This research aims to expand the California Lupus Epidemiology Study (CLUES), which has gathered a diverse group of over 450 individuals with systemic lupus erythematosus (SLE). By collecting extensive clinical data, biological specimens, and patient-reported outcomes, the study seeks to analyze how racial, ethnic, and socioeconomic factors influence SLE outcomes. Participants will provide information on their health, symptoms, and access to healthcare, which will help researchers identify gaps and improve care for lupus patients. The findings could lead to better understanding and management of SLE in diverse populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with systemic lupus erythematosus, particularly those from racially and ethnically diverse backgrounds.
Not a fit: Patients who do not have systemic lupus erythematosus or those outside the targeted demographic groups may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and healthcare access for lupus patients from diverse backgrounds.
How similar studies have performed: Previous research has shown success in understanding health disparities in other chronic conditions, suggesting that this approach could yield valuable insights for lupus as well.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Dall'era, Maria — University of California, San Francisco
- Study coordinator: Dall'era, Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.